Podcast
Podcast: This Week in Managed Care—New Drug Pricing Probe and Other Health News
Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
Every week, The American Journal of Managed Care® (AJMC®) recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
This week, the top managed care news included a new investigation into drug prices; FDA Commissioner Scott Gottlieb, MD, provided updates on how the government shutdown is impacting FDA work; research found comorbidities impede clinical trial participation for patients with cancer.
You may need to log in to the website to access this podcast.
Listen above or through one of these podcast services:
Biologics, Diabetes, Cancer Drugs on House Oversight Probe List
HHS Medicare Drug Shift Plan Could Reduce Costs Overall but Raise Them for Some, Researchers Say
What We're Reading: FDA Resumes Some Inspections; Walmart Leaves CVS' PBM Networks; Flu Season
Comorbidities Impede Clinical Trial Participation Among Patients With Cancer
Understanding What Drives Health Information Exchange Use During Postacute Care Transitions
The American Journal of Managed Care®—January 2019, Health IT Issue
Read more about the stories in this podcast:
